Covid Pfizer (PFE) earnings Q1 2022


Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange.

Drew Angerer | Getty Images

Pfizer on Tuesday cut its 2022 earnings guidance, despite reporting first quarter results that beat on the top and bottom line due to strong Covid vaccine and antiviral sales.

The pharmaceutical giant now expects earnings per share of $6.25 to $6.45 per share for the year, down from its previous outlook of $6.35 to $6.55 per share. Pfizer attributed its lower earnings guidance to research and development costs, as well as foreign exchange as the U.S. dollar strengthened against other currencies. However, the company is still…

Source cnbc.com

0 0 votes
Article Rating

Peter Thiel’s New Zealand lodge should be rejected, council planner says

Previous article

Job openings and the level of people quitting their jobs reached records in March

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings